These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17465739)

  • 1. Regulation of tissue-engineered products in the European Union: where are we heading?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2006 Sep; 1(5):709-14. PubMed ID: 17465739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory structures for gene therapy medicinal products in the European Union.
    Klug B; Celis P; Carr M; Reinhardt J
    Methods Enzymol; 2012; 507():337-54. PubMed ID: 22365782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues with Tissues: Trends in Tissue-Engineered Products in Clinical Trials in the European Union.
    Joyce K; Buljovcic Z; Rosic G; Kaszkin-Bettag M; Pandit A
    Tissue Eng Part B Rev; 2023 Feb; 29(1):78-88. PubMed ID: 36062927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A European regulatory pathway for tissue engineering--at last.
    Williams D
    Med Device Technol; 2007 Sep; 18(5):8, 10-1. PubMed ID: 17939364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU.
    Brévignon-Dodin L
    Biomed Mater Eng; 2010; 20(3):121-6. PubMed ID: 20930319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced therapy: from European regulatory framework to national regulatory framework].
    Lucas-Samuel S
    Transfus Clin Biol; 2013 May; 20(2):221-4. PubMed ID: 23517820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of the directive on tissue engineering of the European union.
    Trommelmans L; Selling J; Dierickx K
    Tissue Eng; 2007 Apr; 13(4):667-72. PubMed ID: 17253926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products].
    Chabannon C; Sabatier F; Rial-Sebbag E; Calmels B; Veran J; Magalon G; Lemarie C; Mahalatchimy A
    Med Sci (Paris); 2014 May; 30(5):576-83. PubMed ID: 24939546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can be learnt from the Japanese regulatory approach to tissue engineered products?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2007 Nov; 2(6):967-71. PubMed ID: 18034634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation Policy on Cell- and Tissue-Based Therapy Products in Korea.
    Lim JO
    Tissue Eng Part A; 2015 Dec; 21(23-24):2791-6. PubMed ID: 25759938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current State of Advanced Therapy Medicinal Products in the Czech Republic.
    Kočí Z; Boráň T; Krůpa P; Kubinová Š
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):132-147. PubMed ID: 29869533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supervision, administration and standard research related to tissue engineered medical products].
    Xi TF; Chen L; Zhao P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):480-7. PubMed ID: 14663949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European regulation for therapeutic use of stem cells.
    Ferry N
    Biomed Mater Eng; 2017; 28(s1):S3-S7. PubMed ID: 28372273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory barriers to tissue-engineered products.
    Schutte E
    Med Device Technol; 2002 Mar; 13(2):27-9. PubMed ID: 11984990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a cell-based medicinal product: regulatory structures in the European Union.
    Gálvez P; Clares B; Hmadcha A; Ruiz A; Soria B
    Br Med Bull; 2013; 105():85-105. PubMed ID: 23184855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone tissue engineering - a field for new medicinal products?
    Lewandowska-Szumiel M; Wójtowicz J
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1850-9. PubMed ID: 21902633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Legal regulation in the field of tissue engineering].
    Farkas B; Bárdos T; Bellyei A; Illés T
    Orv Hetil; 2008 Jun; 149(22):1023-8. PubMed ID: 18508736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].
    Reiss M; Büttel IC; Schneider CK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):822-30. PubMed ID: 21698535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital Exemption for Advanced Therapy Medicinal Products: Issue in Application in the European Union Member States.
    Ivaskiene T; Mauricas M; Ivaska J
    Curr Stem Cell Res Ther; 2017; 12(1):45-51. PubMed ID: 27412678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.